3M
Specialty3M is a specialty pharmaceutical company focused on Infectious Disease.
3M's Key Drugs
3M's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
3M's Recent FDA Approvals
New NDA/BLA approvals for 3M over the last two years — novel drugs only, excluding generics and label supplements.
3M's Therapeutic Areas
3M's approved drugs and pipeline span 1 therapeutic area, led by Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
3M's Top Competitors
3M's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
3M Pipeline Snapshot
3M has 1 active clinical program from ClinicalTrials.gov — 1 Phase 3, 0 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1956-03-09
- Latest
- 2009-03-13
- Applications
- 20